Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
NCT00765804
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndrome
Interventions
DRUG:
EGP-437 with EyeGate® II System
DRUG:
Sodium citrate buffer solution with EyeGate® II System
Sponsor
Eyegate Pharmaceuticals, Inc.